💨 Abstract

Hundreds of people reported gut issues, including deaths, after taking GLP-1 drugs used for weightloss. However, these deaths haven't been conclusively attributed to the drugs yet. Now, the NHS will roll out the weight loss jab Mounjaro to 220,000 patients with a BMI over 40. The MHRA and Genomics England are studying potential genetic links between these adverse gastrointestinal reactions and the drugs.

Courtesy: Jen Mills